|
|
Peterlabs Holdings Bhd
BM •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/05/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBM
Market Capitalization66.05 mln
Float64.79 mln
P / E
23.50
Premium valuation
Relative Strength
21
/ 100
Significantly lagging
Key Fundamentals
EPS0.01
P/E23.50
ROE1.04
RPS0.55
ROA0.70
Interest Cover2.50
EBITDA, mln1.69
EV / EBITDA44.21
EV / EBIT44.21
Revenue, mln152
EV / Revenue0.49
Financial Strength
Altman Z-Score3.36
Piotroski F-Score
5
/ 9
Beneish M-Score-2.67
Price to Intrinsic Value0.65
Price to Graham Number1.85
Shiller PE Ratio12.35
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-4.08% |
19
/ 100
 |
| 1 Month |
-9.62% |
13
/ 100
 |
| 2 Months |
0% |
65
/ 100
 |
| 6 Months |
-17.54% |
25
/ 100
 |
| 1 Year |
23.68% |
82
/ 100
 |
|
| |
